Clinical Trials Logo

Skin Aging clinical trials

View clinical trials related to Skin Aging.

Filter by:

NCT ID: NCT03424148 Completed - Skin Aging Clinical Trials

Open-label, Prospective, Multicenter Study to Evaluate the Cutera Excel V™ Laser and a Micro-Lens Array Attachment

Start date: February 20, 2018
Phase: N/A
Study type: Interventional

Open-label, Prospective, Study to Evaluate the Cutera excel V laser at 532 nm in a low fluence, high repetition rate mode and the Micro-Lens Array attachment used with excel V laser at 1064 nm and 532 nm for the improvement of skin quality.

NCT ID: NCT03312543 Completed - Skin Aging Clinical Trials

Evaluation of the Efficacy and Tolerance of a Light Therapy Mask on Mild to Moderate Brown Spots and Moderate to Severe Facial Wrinkles

Start date: October 9, 2017
Phase: N/A
Study type: Interventional

This research study will test how well a light therapy mask works for women with mild to moderate hyperpigmentation (brown spots) and moderate to severe facial wrinkles, as compared to a "sham" or inactive investigational light therapy mask. The study will also test if the light therapy mask causes any irritation. For the first 12 weeks of the study, participants will use the assigned mask, along with a provided cleanser and sunscreen. For the second 12 weeks of the study, participants will use just the cleanser and sunscreen.

NCT ID: NCT03180645 Completed - Skin Aging Clinical Trials

Proof of Concept Anti-ageing Clinical Study in Healthy Subjects

Start date: March 20, 2017
Phase: N/A
Study type: Interventional

The objective of this POC clinical study is to evaluate the moisturising effects on fine lines and wrinkles, texture, barrier function, hydration and elasticity delivered by 4 weeks of twice daily application of the test product on participants presenting visible signs of ageing.

NCT ID: NCT02765763 Completed - Skin Aging Clinical Trials

Clinical Evaluation of Day and Night Skin Care Creams Supplemented With MediCell Technology (MCT)'s Composition of Defensins and Supportive Molecules

Start date: May 2016
Phase: Phase 4
Study type: Interventional

This is a placebo-controlled blinded clinical evaluation of day and night skin care creams supplemented by Medicell Technology's composition of defensins and supportive molecules determine the skin hydration and anti-aging properties of the topical test articles after repeated application to the skin of human subjects.

NCT ID: NCT02580370 Completed - Skin Aging Clinical Trials

Safety and Efficacy of Botulinum Toxin Type A Topical Gel for Lateral Canthal Lines

REALISE 1
Start date: September 2015
Phase: Phase 3
Study type: Interventional

This is a safety and efficacy study of botulinum toxin type A in subjects with lateral canthal lines.

NCT ID: NCT02104960 Completed - Skin Aging Clinical Trials

Study of Skin Parameters in the PROOF Cohort

PEAU PROOF
Start date: March 2013
Phase: N/A
Study type: Observational

This study aims to evaluate skin aging of an homogeneous population of 77 years old patient selected among the PROOF cohort who has been continuously investigated by cardiological examination. Skin aging will be explored by macroscopic and microscopic evaluation. In particular, skin aging will be measured by an index of clinical aging (SCINEXA) and other complementary measures such as facial photos, standard and High Definition dermoscopy, elastography, sebumetry, in vivo and ex vivo confocal microscopy, and classical histological examinations.

NCT ID: NCT02003833 Completed - Skin Aging Clinical Trials

Poly-L-lactic Acid for Skin Quality

Start date: September 2013
Phase: Phase 4
Study type: Interventional

Anecdotal evidence suggests that patients' skin quality may improve as a result of poly-L-lactic acid injection. While this is not the primary goal of such treatments it is often seen and described as so called "Sculptra glow". The aim of this study is to evaluate the effect of repeated subcutaneous injections of poly-L-lactic acid (Sculptra Aesthetic) on skin quality. Participating subjects will be part of the study for about 15 months. There will be an initial treatment period of up to 12 weeks, followed by a 12-month follow-up period. There will be a total of 7 scheduled visits. This study is a double-blind, randomized study. "Double-blind" means that neither the subjects nor the study doctor will know who is receiving Sculptra Aesthetic or placebo. "Randomized" means that the group subjects will be placed in is decided by chance, similar to drawing numbers out of a hat or flipping a coin. Subjects will have a 1 out of 2 chance of receiving the active study drug. After the completion of the study, if subjects are assigned to the control (placebo) group they will receive free injections with Sculptra Aesthetic same as the treatment group.

NCT ID: NCT01981980 Completed - Skin Aging Clinical Trials

Comparison of the Effects of Carboxytherapy and Radiofrequency on Skin Rejuvenation

Start date: October 2009
Phase: N/A
Study type: Interventional

Carboxytherapy (CA) refers to the cutaneous and subcutaneous administration of carbon dioxide gas [CO2] for therapeutic purposes. Radiofrequency (RF) is a method that uses electric current to generate heat into the layers of the skin and the subcutaneous tissue. Both techniques are indicated to the treatment of skin laxity. The aim of this study was to compare the effects of CA an RF on human skin. Methods: Eight patients who underwent abdominoplasty surgery received a single procedure of both treatments. Untreated skin was used as control. In an area of 49 cm2 (7 x 7 cm) in the infra-umbilical region CA was performed on the right and RF on the left side. Sample collection period ranged from zero to 120 days. CA was administered at a velocity of 40 ml/min, and the total quantity of CO2 infused was approximately 20ml. RF was carried out in a temperature higher than 40ºC on the epidermis for 5 minutes after reaching this temperature.

NCT ID: NCT01940991 Completed - Skin Aging Clinical Trials

Efficacy and Safety of Botulinum Toxin Type A for Moderate to Severe Crow's Feet Lines

Start date: August 2013
Phase: Phase 2
Study type: Interventional

This study will confirm the efficacy and safety of a single topical administration of botulinum toxin type A compared to placebo control for the treatment of moderate to severe crow's feet lines

NCT ID: NCT01791920 Completed - Skin Aging Clinical Trials

To Evaluate the Safety and Efficacy of Botulax® Are Not Inferior to Those of Botox® in the Treatment of Glabellar Lines

Start date: August 2011
Phase: Phase 3
Study type: Interventional

To compare the safety and efficacy of Botulax® with Botox® in the improvement of moderate to severe glabellar lines.